Nonalcoholic fatty liver disease (NAFLD) is accompanied by excessive reactive oxygen species (ROS) production, which has been suggested in several studies to link with mitochondrial function. However, the mechanistic role of ROS-mediated regulation of mitochondrial function in NAFLD has not been elucidated. Since peroxiredoxin 6 (PRDX6) is the only member of the antioxidant PRDX family that translocates to damaged mitochondria, we investigated the PRDX6-mediated antisteatotic mechanism using genetically modified mice and cells.
Results:
PRDX6 mice were more protective to lipid accumulation, liver injury, and insulin resistance after a high-fat diet. Mechanistically, PRDX6 is required for induction of mitochondrial antioxidant action and beta-oxidation through maintaining mitochondrial integrity and subsequently prevents ROS-induced lipogenesis. Interestingly, oxidative stress-induced Notch signaling was suppressed in PRDX6 mice compared with wild-type mice, and genetic and pharmacological inhibition of Notch signaling improved lipid accumulation. Finally, PRDX knockdown or Notch inhibition reduced induction of mitophagy. PRDX6 antagonizes positive feedback loop between lipid accumulation and ROS production through regulation of mitochondrial function.
Innovation:
For the first time, we demonstrate that PRDX6 maintains mitochondria integrity under oxidative stress and protects against NAFLD progression by inhibition of Notch signaling.
Conclusion:
This study describes a novel molecular mechanism underlying the antisteatotic activity of PRDX6, which may be a new therapeutic strategy for the treatment of NAFLD.
Get full access to this article
View all access options for this article.
References
1.
AounM, FouretG, MichelF, BonafosB, RamosJ, CristolJP, CarbonneauMA, CoudrayC, and Feillet-CoudrayC. Dietary fatty acids modulate liver mitochondrial cardiolipin content and its fatty acid composition in rats with non alcoholic fatty liver disease. J Bioenerg Biomembr, 44: 439–452, 2012.
2.
ArmstrongD and BrowneR. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol, 366: 43–58, 1994.
3.
BeltowskiJ, WojcickaG, GornyD, and MarciniakA. The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol, 51: 883–896, 2000.
4.
BiP, ShanT, LiuW, YueF, YangX, LiangXR, WangJ, LiJ, CarlessoN, LiuX, and KuangS. Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity. Nat Med, 20: 911–918, 2014.
5.
BolosV, Grego-BessaJ, and de la PompaJL. Notch signaling in development and cancer. Endocr Rev, 28: 339–363, 2007.
6.
BoopathyAV, PendergrassKD, ChePL, YoonYS, and DavisME. Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells. Stem Cell Res Ther, 4: 43, 2013.
7.
ChangTS, JeongW, WooHA, LeeSM, ParkS, and RheeSG. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J Biol Chem, 279: 50994–51001, 2004.
8.
Feillet-CoudrayC, SutraT, FouretG, RamosJ, Wrutniak-CabelloC, CabelloG, CristolJP, and CoudrayC. Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med, 46: 624–632, 2009.
9.
FisherAB. Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A(2) activities. Antioxid Redox Signal, 15: 831–844, 2011.
10.
FontanaL, ZhaoE, AmirM, DongH, TanakaK, and CzajaMJ. Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. Hepatology, 57: 995–1004, 2013.
11.
HarrisonSA, TorgersonS, HayashiP, WardJ, and SchenkerS. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol, 98: 2485–2490, 2003.
12.
HernandezG, ThorntonC, StotlandA, LuiD, SinJ, RamilJ, MageeN, AndresA, QuaratoG, CarreiraRS, SayenMR, WolkowiczR, and GottliebRA. MitoTimer: a novel tool for monitoring mitochondrial turnover. Autophagy, 9: 1852–1861, 2013.
13.
HortonJD, GoldsteinJL, and BrownMS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest, 109: 1125–1131, 2002.
14.
HuhJY, KimY, JeongJ, ParkJ, KimI, HuhKH, KimYS, WooHA, RheeSG, LeeKJ, and HaH. Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression. Antioxid Redox Signal, 16: 229–243, 2012.
15.
HwangLL, WangCH, LiTL, ChangSD, LinLC, ChenCP, ChenCT, LiangKC, HoIK, YangWS, and ChiouLC. Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice. Obesity (Silver Spring), 18: 463–469, 2010.
16.
KamareheiM and YazdanparastR. Modulation of notch signaling pathway to prevent H2O2/menadione-induced SK-N-MC cells death by EUK134. Cell Mol Neurobiol, 34: 1037–1045, 2014.
17.
KanetoH, KatakamiN, KawamoriD, MiyatsukaT, SakamotoK, MatsuokaTA, MatsuhisaM, and YamasakiY. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal, 9: 355–366, 2007.
18.
LieberCS, LeoMA, MakKM, XuY, CaoQ, RenC, PonomarenkoA, and DeCarliLM. Model of nonalcoholic steatohepatitis. Am J Clin Nutr, 79: 502–509, 2004.
19.
LiuJF, MaY, WangY, DuZY, ShenJK, and PengHL. Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress. Phytother Res, 25: 588–596, 2011.
20.
LuY and CederbaumAI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med, 44: 723–738, 2008.
21.
MaS, ZhangX, ZhengL, LiZ, ZhaoX, LaiW, ShenH, LvJ, YangG, WangQ, and JiJ. Peroxiredoxin 6 is a crucial factor in the initial step of mitochondrial clearance and is upstream of the PINK1-parkin pathway. Antioxid Redox Signal, 24: 486–501, 2016.
22.
ManevichY, HutchensS, HalushkaPV, TewKD, TownsendDM, JauchEC, and BorgK. Peroxiredoxin VI oxidation in cerebrospinal fluid correlates with traumatic brain injury outcome. Free Radic Biol Med, 72: 210–221, 2014.
23.
MurphyMP. Mitochondrial dysfunction indirectly elevates ROS production by the endoplasmic reticulum. Cell Metab, 18: 145–146, 2013.
24.
NabeshimaA, YamadaS, GuoX, TanimotoA, WangKY, ShimajiriS, KimuraS, TasakiT, NoguchiH, KitadaS, WatanabeT, FujiiJ, KohnoK, and SasaguriY. Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. Antioxid Redox Signal, 19: 1983–1998, 2013.
25.
Neuschwander-TetriBA. Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH. Curr Gastroenterol Rep, 12: 49–56, 2010.
26.
OlusiSO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord, 26: 1159–1164, 2002.
27.
OtaT, TakamuraT, KuritaS, MatsuzawaN, KitaY, UnoM, AkahoriH, MisuH, SakuraiM, ZenY, NakanumaY, and KanekoS. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology, 132: 282–293, 2007.
28.
PacificiF, ArrigaR, SoriceGP, CapuaniB, ScioliMG, PastoreD, DonadelG, BelliaA, CaratelliS, CoppolaA, FerrelliF, FedericiM, SconocchiaG, TesauroM, SbracciaP, Della-MorteD, GiaccariA, OrlandiA, and LauroD. Peroxiredoxin 6, a novel player in the pathogenesis of diabetes. Diabetes, 63: 3210–3220, 2014.
29.
PajvaniUB, QiangL, KangsamaksinT, KitajewskiJ, GinsbergHN, and AcciliD. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med, 19: 1054–1060, 2013.
30.
PajvaniUB, ShawberCJ, SamuelVT, BirkenfeldAL, ShulmanGI, KitajewskiJ, and AcciliD. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med, 17: 961–967, 2011.
31.
PhelanSA, WangX, WallbrandtP, Forsman-SembK, and PaigenB. Overexpression of Prdx6 reduces H2O2 but does not prevent diet-induced atherosclerosis in the aortic root. Free Radic Biol Med, 35: 1110–1120, 2003.
32.
SahiniN and BorlakJ. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog Lipid Res, 54: 86–112, 2014.
33.
SchlameM, RuaD, and GreenbergML. The biosynthesis and functional role of cardiolipin. Prog Lipid Res, 39: 257–288, 2000.
34.
SchmidGM, ConversetV, WalterN, SennittMV, LeungKY, ByersH, WardM, HochstrasserDF, CawthorneMA, and SanchezJC. Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice. Proteomics, 4: 2270–2282, 2004.
35.
SchwemmerM, FinkB, KockerbauerR, and BassengeE. How urine analysis reflects oxidative stress—nitrotyrosine as a potential marker. Clin Chim Acta, 297: 207–216, 2000.
36.
SekiyaM, HiraishiA, TouyamaM, and SakamotoK. Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells. Biochem Biophys Res Commun, 375: 602–607, 2008.
37.
ShengB, GongK, NiuY, LiuL, YanY, LuG, ZhangL, HuM, ZhaoN, ZhangX, TangP, and GongY. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: implications for the treatment of Alzheimer's disease. Free Radic Biol Med, 46: 1362–1375, 2009.
StephenS, BaranovaA, and YounossiZM. Nonalcoholic fatty liver disease and bariatric surgery. Expert Rev Gastroenterol Hepatol, 6: 163–171, 2012.
40.
SunN, YunJ, LiuJ, MalideD, LiuC, RoviraII, HolmstromKM, FergussonMM, YooYH, CombsCA, and FinkelT. Measuring in vivo mitophagy. Mol Cell, 60: 685–696, 2015.
41.
UchiyamaS, ShimizuT, and ShirasawaT. CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J Biol Chem, 281: 31713–31719, 2006.
42.
UtzschneiderKM and KahnSE. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab, 91: 4753–4761, 2006.
43.
VidelaLA, RodrigoR, OrellanaM, FernandezV, TapiaG, QuinonesL, VarelaN, ContrerasJ, LazarteR, CsendesA, RojasJ, MaluendaF, BurdilesP, DiazJC, SmokG, ThielemannL, and PoniachikJ. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond), 106: 261–268, 2004.
44.
WangC, LiX, WangH, XieQ, and XuY. Notch1-nuclear factor kappaB involves in oxidative stress-induced alcoholic steatohepatitis. Alcohol Alcohol, 49: 10–16, 2014.
45.
WangL, JiangZ, and LeiXG. Knockout of SOD1 alters murine hepatic glycolysis, gluconeogenesis, and lipogenesis. Free Radic Biol Med, 53: 1689–1696, 2012.
46.
WangX, PhelanSA, Forsman-SembK, TaylorEF, PetrosC, BrownA, LernerCP, and PaigenB. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J Biol Chem, 278: 25179–25190, 2003.
47.
WeirGC and Bonner-WeirS. Islet beta cell mass in diabetes and how it relates to function, birth, and death. Ann N Y Acad Sci, 1281: 92–105, 2013.
48.
WiswedelI, GardemannA, StorchA, PeterD, and SchildL. Degradation of phospholipids by oxidative stress—exceptional significance of cardiolipin. Free Radic Res, 44: 135–145, 2010.
ZhangX, DongF, RenJ, DriscollMJ, and CulverB. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol, 191: 318–325, 2005.
51.
ZhangX and ZhangK. Endoplasmic reticulum stress-associated lipid droplet formation and type II diabetes. Biochem Res Int, 2012: 247275, 2012.
52.
ZhaoNJ, LiaoMJ, WuJJ, and ChuKX. Curcumin suppresses Notch1 signaling: improvements in fatty liver and insulin resistance in rats. Mol Med Rep, 17: 819–826, 2018.
53.
ZongH, ArmoniM, HarelC, KarnieliE, and PessinJE. Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab, 302: E532–E539, 2012.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
